Fuller & Thaler Asset Management’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
Other funds holding GH
VCM
VPM
Fuller & Thaler Asset Management's GH Position: Q2 2026 in Review
Fuller & Thaler Asset Management increased its Guardant Health (GH) stake by 3.1% in Q2 2026, buying an estimated $8.56M and bringing the position to 2,629,007 shares worth $394M. The position accounts for 1.07% of the portfolio, ranked #11.
Fuller & Thaler Asset Management first reported a position in GH in Q2 2019 and has held it in 18 quarters since. 422 funds tracked by Wall St. Rank hold GH as of Q2 2026.
- Fuller & Thaler Asset Management held 2,629,007 shares of Guardant Health worth $394M as of Q2 2026.
- Fuller & Thaler Asset Management bought 78,693 Guardant Health shares in Q2 2026, an estimated $8.56M.
- Guardant Health made up 1.07% of Fuller & Thaler Asset Management's portfolio in Q2 2026, its #11 holding.
- Fuller & Thaler Asset Management first reported a position in Guardant Health in Q2 2019 and has held it in 18 quarters since.
- 422 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.
Based on Fuller & Thaler Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.